Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse

Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse data. More information is available at https://adni.loni.usc.edu/data-samples/adni-data/

Usage

data(FUJIREBIOABETAPLASMA)

A data frame with 514 observations and 11 variables.

ORIGPROT character Original study protocol , with options: ADNI1, ADNI2, ADNIGO
RID numeric Participant roster ID Range value: 31, ..., 5263
VISCODE character Record time of visit , with options: v41, v51, init, v21, v52
VISCODE2 character Record time of visit by month
EXAMDATE Record time of visit by date Date: YYY-MM-DD
SPECIMEN_TYPE character Specimen sample type - plasma , with options: Plasma
ANALYTE character Biomarker analyte tested , with options: AB142P, AB140P
COUNT numeric Sample count Range value: 8339, ..., 204336
CONCENTRATION numeric Concentration of biomarker in pg/ml Range value: 14.57, ..., 555.7
MM_NUMBER numeric For samples tested in duplicate sample test 1 or 2 Range value: 1, ..., 2
update_stamp POSIXct: YYY-MM-DD